University Of Pecs

4 trials 2 recruiting Commercial sponsor

Filter these 4 trials by condition, phase, country and more.

Open in Search →

4 Registered trials

2 Recruiting

0 Completed trials

7 Countries active

6 Unique IMPs

N/A Results reported

Phase III

Phase II

Phase IV

Phase I

Phase III: 1 Phase II: 1 Phase IV: 1 Phase I: 1

Top IMPs

LYOPHILIZED BACTERIAL LYSATES OF: HAEMOPHILUS INFLUENZAE STREPTOCOCCUS (DIPLOCOCCUS) PNEUMONIAE KLEBSIELLA PNEUMONIAE AND OZAENAE STAPHYLOCOCCUS AUREUS STREPTOCOCCUS PYOGENES AND VIRIDANS MORAXELLA (BRANHAMELLA / NEISSERIA) CATARRHALIS 1

All trials

4 total

Impact of Biweekly and Triweekly Dosing Regimens Pending

2025-522305-38-00 Phase II 1 country
The effect of Broncho-Vaxom on the COPD exacerbations in terms of lung function, lung mechanics, immune state, body composition, quality of … Pending

2025-524501-32-02 Phase IV 1 country LYOPHILIZED BACTERIAL LYSATES OF: HAEMOPHILUS INFLUENZAE STREPTOCOCCUS (DIPLOCOC…
A PHASE I, COMBINED STUDY OF THE SAFETY, TOLERABILITY, AND PHARMACOKINETICS OF SZV-1287 IN HEALTHY MALE VOLUNTEERS AFTER SINGLE ASCENDING AN… Recruiting

2024-519485-50-00 Phase I 1 country
First-line catheter ablation for early treatment of Persistent (ongoing unless cardioverted) Atrial Fibrillation (AF) – a randomized study … Recruiting

2023-505962-28-00 Phase III 7 countries

Showing 1–4 of 4 trials

← All sponsors A–Z